SpyGlass Pharma Inc. Common Stock
SGP | NASDAQ
$32.39
-$0.12 (-0.37%)
At close: Oct 30, 2026, 3:59 PM ET
$32.24
-$0.15 (-0.46%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Net Income | -39.87M |
Depreciation & Amortization | 612K |
Stock-Based Compensation | 2.79M |
Other Working Capital | 1.91M |
Other Non-Cash Items | 1.32M |
Deferred Income Tax | n/a |
Change in Working Capital | 2.45M |
Operating Cash Flow | -32.7M |
Capital Expenditures | -789K |
Cash Acquisitions | n/a |
Purchase of Investments | -17M |
Sales Maturities Of Investments | 6M |
Other Investing Acitivies | n/a |
Investing Cash Flow | -11.79M |
Debt Repayment | n/a |
Common Stock Repurchased | -1.45M |
Dividend Paid | n/a |
Other Financial Acitivies | -1.47M |
Financial Cash Flow | 124.59M |
Net Cash Flow | 80.09M |
Free Cash Flow | -33.49M |
Adj. Free Cash Flow | -36.28M |
Maintenance CapEx | -612K |
Growth CapEx | -177K |
Owner Earnings | -33.31M |
Add to Watchlist
Select watchlists to add or remove SGP